Exact(23)
Risk of mortality was significantly higher in the cases (odds ratio, 1.32).
Given significant heterogeneity in the pattern of CAG biallelic mean distribution of the obese and lean PCOS cases, odds were also computed for the pooled range of CAG repeats on both sides (<18 or >20) vis-à-vis the middle range (18 20), considering the pooled case cohort versus controls (Table 4) and the lean versus obese PCOS cases (Table 5).
A significant excess of the valine genotypes was observed among the cases (odds ratio 1.43, 95% confidence interval 1.02 2.00).
#Clusters of 4 cases compared with clusters of 3 cases odds ratio 1.87, 95% confidence interval 0.52 6.66.
In all cases, odds ratios (OR) with 95% confidence intervals (CI) associated with p-values < 0.05 were considered statistically significant.
Chronic pneumonia was associated with fibrinous pleuritis in 17 (33.3%) cases (odds ratio (OR) = 9.2; CI = 2.9-29.1; P < 0.01).
Similar(37)
Odds ratios comparing each subtype to all controls and case-case odds ratios comparing mammographic density distributions in basal-like to luminal A breast cancers were estimated using logistic regression.
Taking the exponential of this coefficient indicates how the odds of belonging to the latent group getting a zero outcome are affected; in this case, odds are affected by a factor 0.11.
Case-case odds ratios were calculated in order to measure the risk heterogeneity between HER-2/ neu+ and HER-2/ neu-tumours.
Additionally, case-case odds ratios were calculated in order to measure the risk heterogeneity between HER-2/ neu+ and HER-2/ neu-tumours.
In a univariate analysis, having a documented previous TB episode was significantly associated with being an MDR-TB case (odds ratio [OR] = 28.7, 95% confidence interval [CI] 10.3 80.5).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com